TipRanks
Drugs Made In America Acquisition Corp. (DMAA)
NASDAQ:DMAA
US Market
DMAA
Drugs Made In America Acquisition Corp.
RESEARCH TOOLSreports

Drugs Made In America Acquisition Corp. (DMAA) Income Statement

2 Followers

Drugs Made In America Acquisition Corp. Income Statement

Last quarter (Q2 2026), Drugs Made In America Acquisition Corp.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Drugs Made In America Acquisition Corp.'s net income was $1.73M. See Drugs Made In America Acquisition Corp.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24
Total Revenue
$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00
Operating Expenses
$ 2.82M-
Depreciation and Amortization
$ 0.00-
EBITDA
$ -2.82M$ -279.85K
Operating Income
$ -2.82M$ -479.00
Other Income/Expenses
$ 8.76M$ 0.00
Pretax Income
$ 5.94M$ -479.00
Net Income
$ 5.94M$ -479.00
Per Share Metrics
Basic EPS
$ 0.19$ -0.06
Diluted EPS
$ 0.19$ -0.06
Weighted Average Shares Outstanding
 21.01M 8.57M
Weighted Average Shares Outstanding (Diluted)
 21.01M 8.57M
Currency in USD

Drugs Made In America Acquisition Corp. Earnings and Revenue History